Shenzhen GuoHua Network Security Technology Co., Ltd. (SHE:000004)
China · Delayed Price · Currency is CNY 2.760
-0.150 (-5.15%)
Apr 29, 2026, 8:51 AM CST
SHE:000004 Revenue
In the year 2025, Shenzhen GuoHua Network Security Technology had annual revenue of 176.96M CNY with 79.36% growth. Shenzhen GuoHua Network Security Technology had revenue of 16.62M in the quarter ending March 31, 2026, a decrease of -9.34%.
Revenue
176.96M
Revenue Growth
+79.36%
P/S Ratio
2.06
Revenue / Employee
585.95K
Employees
302
Market Cap
365.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 176.96M | 78.30M | 79.36% |
| Dec 31, 2024 | 98.66M | -11.39M | -10.35% |
| Dec 31, 2023 | 110.05M | -56.41M | -33.89% |
| Jan 1, 2023 | 166.46M | -122.48M | -42.39% |
| Jan 1, 2022 | 288.94M | 8.41M | 3.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Universal Biotech | 1.13B |
| Guiyang Xintian Pharmaceutical | 735.18M |
| Jilin Jian Yisheng Pharmaceutical | 659.66M |
| Sailong Pharmaceutical Group | 618.17M |
| Tiansheng Pharmaceutical Group | 514.09M |
| Cabio Biotech (Wuhan) | 418.18M |
| Suzhou Fushilai Pharmaceutical | 412.51M |
| Jiangsu CoWin Biotech | 209.51M |